Senti Bio Announces Publication of SENTI-202 Preclinical Data; Says Data Supports The Design Of Phase 1 Clinical Trial With Patient Dosing Anticipated In Q2
Senti Bio Announces Publication of SENTI-202 Preclinical Data; Says Data Supports The Design Of Phase 1 Clinical Trial With Patient Dosing Anticipated In Q2
Senti Bio宣佈發佈 SENTI-202 臨床前數據；稱數據支持1期臨床試驗的設計，患者給藥預計將在第二季度進行
Senti Bio Announces Publication of SENTI-202 Preclinical Data; Says Data Supports The Design Of Phase 1 Clinical Trial With Patient Dosing Anticipated In Q2
Senti Bio宣佈發佈 SENTI-202 臨床前數據；稱數據支持1期臨床試驗的設計，患者給藥預計將在第二季度進行
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。